We Support Clinical Development with Global Standards in Asia
Since 1999, we have been the first Japanese CRO to establish a subsidiary in China and the region and have started to provide clinical development services. EPS International Co., Ltd was established in 2007 and EPS China Co., Ltd was established in 2011 to enhance our global clinical development business.
Through partnership with leading global CROs based in Europe and in the U.S, we support Asian-study and Global-study with high quality standard in a cost-effective way.We also provide consultations for overseas bio-venture companies to support product launch in Japan.


【Overseas Coordination Support】





- ●Regulatory Expertise
- We are able to manage overall project schedule from drug development to product launched to meet all regulatory requirements in various countries in Asia region.
- ●Relationship Expertise
- We’ve been building up strong relationship with key influence investigators in Asian countries and trial site network. We highly appreciate personal relationships and manage trial operations from study commencement to patient recruitment in the clinical study effectively.
- ●Team Expertise
- We have professionals with vast experience in managing Global-Japan and Global-Asian study coupled with well versed knowledge in overseas circumstances. We are able to provide full range of services to meet both local and global standards.
- ●Resource Expertise
- By utilizing clinical trial management platform of EPS group, we are able to provide multi-services to help research and development of pharmaceutical and medical device and launch the products in worldwide markets.
[ Contact ] Sales Department TEL +81-3-5804-7577 / FAX +81-3-5684-7872
[ Last Update ]
